|
US7776314B2
(en)
|
2002-06-17 |
2010-08-17 |
Grunenthal Gmbh |
Abuse-proofed dosage system
|
|
DE10252667A1
(de)
|
2002-11-11 |
2004-05-27 |
Grünenthal GmbH |
Spirocyclische Cyclohexan-Derivate
|
|
DE102005005446A1
(de)
|
2005-02-04 |
2006-08-10 |
Grünenthal GmbH |
Bruchfeste Darreichungsformen mit retardierter Freisetzung
|
|
DE10336400A1
(de)
|
2003-08-06 |
2005-03-24 |
Grünenthal GmbH |
Gegen Missbrauch gesicherte Darreichungsform
|
|
DE10361596A1
(de)
|
2003-12-24 |
2005-09-29 |
Grünenthal GmbH |
Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
|
|
US20070048228A1
(en)
|
2003-08-06 |
2007-03-01 |
Elisabeth Arkenau-Maric |
Abuse-proofed dosage form
|
|
DE102004032051A1
(de)
|
2004-07-01 |
2006-01-19 |
Grünenthal GmbH |
Verfahren zur Herstellung einer gegen Missbrauch gesicherten, festen Darreichungsform
|
|
US8075872B2
(en)
|
2003-08-06 |
2011-12-13 |
Gruenenthal Gmbh |
Abuse-proofed dosage form
|
|
DE10360793A1
(de)
*
|
2003-12-23 |
2005-07-28 |
Grünenthal GmbH |
Spirocyclische Cyclohexan-Derivate
|
|
DE102004032049A1
(de)
|
2004-07-01 |
2006-01-19 |
Grünenthal GmbH |
Gegen Missbrauch gesicherte, orale Darreichungsform
|
|
DE102005005449A1
(de)
|
2005-02-04 |
2006-08-10 |
Grünenthal GmbH |
Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
|
|
DE102005016460A1
(de)
|
2005-04-11 |
2006-10-19 |
Grünenthal GmbH |
Spriocyclische Cyclohexanderivate zur Behandlung von Substanzabhängigkeit
|
|
DE102006019597A1
(de)
*
|
2006-04-27 |
2007-10-31 |
Grünenthal GmbH |
Spirocyclische Cyclohexan-Derivate
|
|
DE102006033114A1
(de)
*
|
2006-07-18 |
2008-01-24 |
Grünenthal GmbH |
Spirocyclische Azaindol-Derivate
|
|
EP1894938A1
(en)
*
|
2006-08-31 |
2008-03-05 |
Evonik Degussa GmbH |
New cyclopentadienyl, indenyl or fluorenyl substituted phosphine compounds and their use in catalytic reactions
|
|
DE102006046745A1
(de)
*
|
2006-09-29 |
2008-04-03 |
Grünenthal GmbH |
Gemischte ORL1/µ-Agonisten zur Behandlung von Schmerz
|
|
DE102007009319A1
(de)
*
|
2007-02-22 |
2008-08-28 |
Grünenthal GmbH |
Spirocyclische Cyclohexan-Derivate
|
|
DE102007009235A1
(de)
|
2007-02-22 |
2008-09-18 |
Grünenthal GmbH |
Spirocyclische Cyclohexan-Derivate
|
|
DE102007011485A1
(de)
|
2007-03-07 |
2008-09-11 |
Grünenthal GmbH |
Darreichungsform mit erschwertem Missbrauch
|
|
KR101614723B1
(ko)
|
2008-01-11 |
2016-04-22 |
알바니 몰레큘라 리써치, 인크. |
Ｍｃｈ 길항물질로서 (1-아지논)-치환된 피리도인돌
|
|
CA2713128C
(en)
|
2008-01-25 |
2016-04-05 |
Gruenenthal Gmbh |
Pharmaceutical dosage form
|
|
JP5599774B2
(ja)
*
|
2008-03-27 |
2014-10-01 |
グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング |
ヒドロキシメチルシクロヘキシルアミン類
|
|
AU2009228637B2
(en)
|
2008-03-27 |
2013-12-19 |
Grunenthal Gmbh |
(Hetero-)aryl cyclohexane derivatives
|
|
WO2009118174A1
(de)
|
2008-03-27 |
2009-10-01 |
Grünenthal GmbH |
Substituierte cyclohexyldiamine
|
|
PT2260042E
(pt)
*
|
2008-03-27 |
2011-12-06 |
Gruenenthal Gmbh |
Derivados de ciclo-hexano espirocíclicos substituídos
|
|
ATE537143T1
(de)
*
|
2008-03-27 |
2011-12-15 |
Gruenenthal Gmbh |
Spiro(5.5)undecan derivate
|
|
CA2719735A1
(en)
|
2008-03-27 |
2009-10-01 |
Gruenenthal Gmbh |
Substituted 4-aminocyclohexane derivatives
|
|
AU2009243681B2
(en)
|
2008-05-09 |
2013-12-19 |
Grunenthal Gmbh |
Process for the preparation of an intermediate powder formulation and a final solid dosage form under usage of a spray congealing step
|
|
PT2356123E
(pt)
|
2008-11-13 |
2012-10-31 |
Hoffmann La Roche |
Espiro-5,6-di-hidro-4h-2,3,5,10b-tetra-azabenzo[ e]azulenos
|
|
WO2011003007A1
(en)
*
|
2009-07-01 |
2011-01-06 |
Albany Molecular Research, Inc. |
Azabicycloalkane-indole and azabicycloalkane-pyrrolo-pyridine mch-1 antagonists, methods of making, and use thereof
|
|
JP2012532144A
(ja)
*
|
2009-07-01 |
2012-12-13 |
アルバニー モレキュラー リサーチ， インコーポレイテッド |
アジノン置換アゼピノ［ｂ］インドールおよびピリド−ピロロ−アゼピンｍｃｈ−１拮抗薬、ならびにその作製方法および使用
|
|
US8618299B2
(en)
*
|
2009-07-01 |
2013-12-31 |
Albany Molecular Research, Inc. |
Azinone-substituted azapolycycle MCH-1 antagonists, methods of making, and use thereof
|
|
US9073925B2
(en)
*
|
2009-07-01 |
2015-07-07 |
Albany Molecular Research, Inc. |
Azinone-substituted azabicycloalkane-indole and azabicycloalkane-pyrrolo-pyridine MCH-1 antagonists, methods of making, and use thereof
|
|
KR101738369B1
(ko)
|
2009-07-22 |
2017-05-22 |
그뤼넨탈 게엠베하 |
핫 멜트 압출된 제어 방출 투여형
|
|
CN102639118B
(zh)
|
2009-07-22 |
2015-07-29 |
格吕伦塔尔有限公司 |
氧化稳定的抗干扰剂型
|
|
UA107943C2
(xx)
*
|
2009-11-16 |
2015-03-10 |
Lilly Co Eli |
Сполуки спіропіперидину як антагоністи рецептора orl-1
|
|
AU2010319400B2
(en)
*
|
2009-11-16 |
2013-12-19 |
Eli Lilly And Company |
Spiropiperidine compounds as ORL-1 receptor antagonists
|
|
KR101864578B1
(ko)
*
|
2010-06-24 |
2018-06-07 |
레오 파마 에이/에스 |
포스포디에스테라제 억제제로서의 벤조디옥솔 또는 벤조디옥세핀 헤테로사이클릭 화합물
|
|
TWI582092B
(zh)
|
2010-07-28 |
2017-05-11 |
歌林達股份有限公司 |
順式－四氫－螺旋（環己烷－１,１’－吡啶［３,４－b］吲哚）－４－胺－衍生物
|
|
TWI516286B
(zh)
|
2010-09-02 |
2016-01-11 |
歌林達股份有限公司 |
含陰離子聚合物之抗破碎劑型
|
|
BR112013005194A2
(pt)
|
2010-09-02 |
2016-05-03 |
Gruenenthal Gmbh |
forma de dosagem resistente à violação compreendendo sal inorgânico
|
|
CN107308124A
(zh)
|
2010-09-02 |
2017-11-03 |
格吕伦塔尔有限公司 |
包含阴离子聚合物的抗破碎剂型
|
|
US8697700B2
(en)
|
2010-12-21 |
2014-04-15 |
Albany Molecular Research, Inc. |
Piperazinone-substituted tetrahydro-carboline MCH-1 antagonists, methods of making, and uses thereof
|
|
US8993765B2
(en)
|
2010-12-21 |
2015-03-31 |
Albany Molecular Research, Inc. |
Tetrahydro-azacarboline MCH-1 antagonists, methods of making, and uses thereof
|
|
BR112014001091A2
(pt)
|
2011-07-29 |
2017-02-14 |
Gruenenthal Gmbh |
comprimido resistente à adulteração que fornece liberação imediata do fármaco
|
|
EA201400172A1
(ru)
|
2011-07-29 |
2014-06-30 |
Грюненталь Гмбх |
Устойчивая к разрушению таблетка, которая обеспечивает немедленное высвобождение лекарственного средства
|
|
EA025500B1
(ru)
*
|
2012-02-03 |
2016-12-30 |
Грюненталь Гмбх |
(1R,4R)-6'-ФТОР-(N-МЕТИЛ- ИЛИ N,N-ДИМЕТИЛ-)-4-ФЕНИЛ-4',9'-ДИГИДРО-3'Н-СПИРО[ЦИКЛОГЕКСАН-1,1'-ПИРАНО[3,4,b]ИНДОЛ]-4-АМИН ДЛЯ ЛЕЧЕНИЯ ФИБРОМИАЛГИИ И СИНДРОМА ХРОНИЧЕСКОЙ УСТАЛОСТИ
|
|
US20130225625A1
(en)
|
2012-02-28 |
2013-08-29 |
Grunenthal Gmbh |
Tamper-resistant pharmaceutical dosage form comprising nonionic surfactant
|
|
MX356421B
(es)
|
2012-02-28 |
2018-05-29 |
Gruenenthal Gmbh |
Forma de dosificacion resistente a la manipulacion indebida que comprende un compuesto farmacologicamente activo y un polimero anionico.
|
|
EP2838512B1
(en)
|
2012-04-18 |
2018-08-22 |
Grünenthal GmbH |
Tamper resistant and dose-dumping resistant pharmaceutical dosage form
|
|
SI2846835T1
(en)
|
2012-05-11 |
2018-01-31 |
Gruenenthal Gmbh |
Heat-formed pharmaceutical dosage form, resistant to abuse and containing zinc
|
|
US10064945B2
(en)
|
2012-05-11 |
2018-09-04 |
Gruenenthal Gmbh |
Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
|
|
US9855286B2
(en)
*
|
2012-05-18 |
2018-01-02 |
Gruenenthal Gmbh |
Pharmaceutical composition comprising (1r,4r)-6′-fluoro-N,N-di methyl-4-phenyl-4′,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano-[3,4,b]indol]-4-amine and a salicylic acid component
|
|
US20130310385A1
(en)
*
|
2012-05-18 |
2013-11-21 |
Gruenenthal Gmbh |
Pharmaceutical Composition Comprising (1r,4r)-6'-fluoro-N,N-dimethyl-4-phenyl-4',9'-dihydro-3'H-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine and Antidepressants
|
|
US9320729B2
(en)
*
|
2012-05-18 |
2016-04-26 |
Gruenenthal Gmbh |
Pharmaceutical composition comprising (1r,4r)-6′-flouro-N,N-dimethyl-4-phenyl-4′,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano-[3,4,b]indol]-4-amine and a propionic acid derivative
|
|
US9320725B2
(en)
*
|
2012-05-18 |
2016-04-26 |
Gruenenthal Gmbh |
Pharmaceutical composition comprising (1r,4r)-6′-fluoro-N,N-dimethyl-4-phenyl-4′9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano[3,4,b]indol]-4-amine and a gabapentinoid
|
|
US9345689B2
(en)
*
|
2012-05-18 |
2016-05-24 |
Gruenenthal Gmbh |
Pharmaceutical composition comprising (1r,4r)-6′-fluoro-N, N-dimethyl-4-phenyl-4,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano[3,4,b]indol]-4-amine and an anticonvulsant
|
|
US20130310435A1
(en)
*
|
2012-05-18 |
2013-11-21 |
Gruenenthal Gmbh |
Pharmaceutical Composition Comprising (1r,4r)-6'-fluoro-N, N-dimethyl-4-phenyl-4,9' -dihydro-3'H-spiro[cyclohexane-1,1' -pyrano[3,4,b]indol]-4-amine and Paracetamol or Propacetamol
|
|
US8912226B2
(en)
*
|
2012-05-18 |
2014-12-16 |
Gruenenthal Gmbh |
Pharmaceutical composition comprising (1r,4r) -6′-fluoro-N,N-dimethyl-4-phenyl-4′,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano[3,4,b]indol]-4-amine and a NSAR
|
|
US9308196B2
(en)
*
|
2012-05-18 |
2016-04-12 |
Gruenenthal Gmbh |
Pharmaceutical composition comprising (1 r,4r) -6'-fluoro-N ,N-dimethyl-4-phenyl-4',9'-d ihydro-3'H-spiro[cyclohexane-1,1'-pyrano-[3,4,b]indol]-4-amine and an oxicam
|
|
BR112015022509A2
(pt)
|
2013-03-15 |
2017-07-18 |
Gruenenthal Gmbh |
forma cristalina de cis-(e)-4-(3-fluorofenil)-2',3',4',9'-tetra-hidro-n,n-dimetil-2'-(1-oxo-3-fenil-2-propenil)-espiro[ciclohexano-1,1'[1h]-pirido[3,4-b]indol]-4-amina cristalina
|
|
EP3003279A1
(en)
|
2013-05-29 |
2016-04-13 |
Grünenthal GmbH |
Tamper-resistant dosage form containing one or more particles
|
|
US9737490B2
(en)
|
2013-05-29 |
2017-08-22 |
Grünenthal GmbH |
Tamper resistant dosage form with bimodal release profile
|
|
BR112016000194A8
(pt)
|
2013-07-12 |
2019-12-31 |
Gruenenthal Gmbh |
forma de dosagem resistente à violação contendo o polímero de acetato de etileno-vinila
|
|
EP3073994A1
(en)
|
2013-11-26 |
2016-10-05 |
Grünenthal GmbH |
Preparation of a powdery pharmaceutical composition by means of cryo-milling
|
|
WO2015091352A1
(en)
|
2013-12-16 |
2015-06-25 |
Grünenthal GmbH |
Tamper resistant dosage form with bimodal release profile manufactured by co-extrusion
|
|
WO2015173195A1
(en)
|
2014-05-12 |
2015-11-19 |
Grünenthal GmbH |
Tamper resistant immediate release capsule formulation comprising tapentadol
|
|
EA201692388A1
(ru)
|
2014-05-26 |
2017-05-31 |
Грюненталь Гмбх |
Лекарственная форма в виде множества частиц, защищенная от вызываемого этанолом сброса дозы
|
|
TW201607923A
(zh)
|
2014-07-15 |
2016-03-01 |
歌林達有限公司 |
被取代之氮螺環（４．５）癸烷衍生物
|
|
HUE040133T2
(hu)
|
2014-07-15 |
2019-02-28 |
Gruenenthal Gmbh |
Szubsztituált azaspiro(4.5)dekán származékok
|
|
EP3253376A1
(en)
|
2015-02-03 |
2017-12-13 |
Grünenthal GmbH |
Tamper-resistant dosage form comprising a polyethylene glycol graft copolymer
|
|
WO2016170097A1
(en)
|
2015-04-24 |
2016-10-27 |
Grünenthal GmbH |
Tamper-resistant dosage form with immediate release and resistance against solvent extraction
|
|
JP2018526414A
(ja)
|
2015-09-10 |
2018-09-13 |
グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング |
乱用抑止性の即放性製剤を用いた経口過剰摂取に対する保護
|
|
EP3365453A2
(en)
|
2015-10-22 |
2018-08-29 |
Juno Therapeutics GmbH |
Methods, kits, agents and apparatuses for transduction
|
|
AU2017294524A1
(en)
|
2016-07-06 |
2018-12-20 |
Grünenthal GmbH |
Reinforced pharmaceutical dosage form
|
|
GB202306662D0
(en)
|
2023-05-05 |
2023-06-21 |
Union Therapeutics As |
Dosage regimen
|